Evidence map›Paper›PMID 34456134›Full record

ArticleMolecular genetics and metabolism

Natural history of Tay-Sachs disease in sheep.

Brett Story, Toloo Taghian, Jillian Gallagher, Jey Koehler, Amanda Taylor, Ashley Randle, Kayly Nielsen, Amanda Gross, Annie Maguire, Sara Carl and 11 more

Open access · greenAbstract read
In one paragraph

Article in Molecular genetics and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Brett StoryScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Toloo TaghianHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States of America; Department of Radiology, University of Massachusetts Medical School, Worcester, MA, United States of America.
Jillian GallagherHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States of America.
Jey KoehlerDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Amanda TaylorAuburn University, Department of Clinical Sciences Auburn University, Auburn, AL, United States of America.
Ashley RandleScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Kayly NielsenScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Amanda GrossScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Annie MaguireScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America; Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Sara CarlScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Siauna JohnsonScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Deborah FernauHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States of America.
Elise DiffieScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Paul CuddonNeurology Locum, Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, AL.
Carly CoradoBioMarin Pharmaceutical Inc, Novato, CA, United States of America.
Sundeep ChandraBioMarin Pharmaceutical Inc, Novato, CA, United States of America.
Miguel Sena-EstevesHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States of America; Department of Neurology, University of Massachusetts Medical School, Worcester, MA, United States of America.
Edwin KolodnyBernard A. Marden Professor of Neurology and Chairman of the Department of Neurology, New York University, School of Medicine, NY, NY, United States of America; Head of the Division of Neurogenetics, New York University, School of Medicine, NY, NY, United States of America.
Xuntian JiangDepartment of Medicine, Washington University School of Medicine, St. Louis, MI, United States of America.
Douglas MartinDepartment of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America; Neurology Locum, Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, AL.
Heather Gray-EdwardsScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America; Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States of America; Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America; Department of Radiology, University of Massachusetts Medical School, Worcester, MA, United States of America. Electronic address: Heather.GrayEdwards@umassmed.edu.
Auburn University · USUniversity of Massachusetts Chan Medical School · USBioMarin (United States) · USNew York University · USWashington University in St. Louis · US

Funding

Global AAV gene therapy of Tay-Sachs disease in sheep.K08NS096219 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GRAY-EDWARDS, HEATHER L · 2017 to 2021
$906k
NINDS NIH HHS K08 NS096219
6 · The paper itself

Abstract

Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.

Indexed as

Disease Models, AnimalSheepAnimalsBrainMagnetic Resonance ImagingTay-Sachs DiseaseLarge animal modelNeurodegenerationSheepTay-SachsTranslationalVeterinary

Identifiers

PMID34456134
PMCPMC8811770
OpenAlexW3196177427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.